LeMaitre Vascular Q1 Earnings: Will They Repeat History?

LeMaitre Vascular, a Nasdaq-listed medical device company (LMAT), releases Q1 earnings on Tuesday. Analysts predict an 11.4% year-over-year revenue increase, matching last years growth. Despite missing revenue targets in the past, the company aims to maintain momentum, with peers like Intuitive Surgical and Baxter reporting strong growth. The healthcare equipment sector has seen a 6% average share increase last month, but LeMaitre remained flat. The average analyst target stands at $111.22, with the current price at $108.97. Tuesdays report could significantly impact investor decisions. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/20700e5c6a762d0a